Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON35991
NL-OMON35991
Completed
Not Applicable

Assessment and comparison of inflammatory responses upon challenges with glucose, fat, and a combination of glucose and fat - Inflammatory responses upon challenges with glucose and/or fat

TNO0 sites14 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsinflammatory responses, algemene gezondheidfunctioning immune systeminflammatory responses

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
inflammatory responses, algemene gezondheid
Sponsor
TNO
Enrollment
14
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
TNO

Eligibility Criteria

Inclusion Criteria

  • •1\. Healthy as assessed by:
  • •a. The TNO health and lifestyle questionnaire (P9248 F02\)
  • •b. Results of the pre\-study laboratory tests in blood
  • •c. Assessment of physical characteristics
  • •2\. Age 30\-60 y at Day 01 of the study
  • •3\. Body Mass Index (BMI) of 20 \- 25 kg/m2
  • •4\. Voluntary participation
  • •5\. Having given written informed consent
  • •6\. Willing to comply with the study procedures
  • •7\. Willing to give up blood donation during the study

Exclusion Criteria

  • •1\. Participation in any clinical trial including blood sampling and/or administration of substances up to 90 days before Day 01 of this study
  • •2\. Having a history of medical or surgical events that may significantly affect the study outcome (as judged by the medical investigator)
  • •3\. Having a chronic disease related to inflammation or allergy (e.g. rheumatoid arthritis, inflammatory bowel disease, asthma, eczema)
  • •4\. Chronic use of medication that may affect inflammatory processes (e.g. NSAIDs, aspirin, antibiotics)
  • •5\. Regular use of lipid lowering medication and/or cholesterol lowering products (e.g. Becel Pro\-activ)
  • •6\. Lactose intolerance or other food allergies
  • •7\. Reported slimming or medically prescribed diet
  • •8\. Smoking
  • •9\. Alcohol consumption \> 28 units/week for males and \> 21 units/week for females
  • •10\.Extreme physical exercise

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Value of circulating molecular biomarkers (microRNAs) in perioperative period of abdominal sepsis
ACTRN12618001176257Andrius Macas100
Not yet recruiting
Not Applicable
Evaluate systemic inflammatory response and nutritional status before and after chemoradiation in locally advanced upper aero digestive carcinoma patientsHealth Condition 1: D- Radiation Therapy
CTRI/2020/04/024939I
Completed
Not Applicable
Comparison of the acute response of inflammatory markers to circular resistance training in the morning and evening in obese meComparison of the acute response of some inflammatory markers to circular resistance training in the morning and evening.
IRCT20191228045918N1Sabzevar University of Medical Sciences20
Recruiting
Not Applicable
To determine effect of Different teeth capping material on gingival health.
CTRI/2022/09/046085Mohan Mahajan
Recruiting
Not Applicable
Evaluation of the inflammation and effects of dental denture during orthodontic treatmeOrthodontic bracketsgingival crevicular fluidDental enamelE06.658.453.590A12.383.500A14.549.167.900.255
RBR-3sqsh8Centro Universitário do Maranhão